The Centre has positioned an order to acquire 66 crore extra doses of Covishield and Covaxin to be equipped between August and December this yr, at a revised value of Rs 205 and Rs 215 per dose, respectively, excluding taxes, official sources mentioned.
They mentioned 37.5 crore of Covishield doses from the Serum Institute of India and 28.5 crore Covaxin doses from Bharat Biotech might be procured by December.
“An order to acquire 66 crore extra doses of COVID-19 vaccines–Covishield and Covaxin–to be equipped between August and December, at a revised value of Rs 205 and Rs 215 per dose, respectively, excluding taxes, has been positioned,” the supply instructed information company Press Belief of India.
The value of every dose of Covishield quantities to Rs 215.25 and Covaxin Rs 225.75, together with taxes, it mentioned.
The Union well being ministry which was procuring each the vaccines at Rs 150 per dose, had indicated that the costs could be revised after the brand new COVID-19 vaccine procurement coverage got here into impact from June 21. Beneath the brand new coverage, the ministry will procure 75 per cent of the vaccines being produced by the drug producers within the nation.
Whereas the Centre has requested each the vaccine manufacturing companies to scale up their manufacturing, the producers had indicated that getting Rs 150 for every dose whereas making investments to ramp up the manufacturing was not viable for them, sources instructed Press Belief of India.
The Union authorities had earlier allowed states and personal hospitals to acquire 50 per cent of the vaccines following calls for for decentralisation of the method.
Nevertheless, after a number of states complained of issues together with of funding, Prime Minister Narendra Modi introduced the revision of the vaccine pointers on June 8.
Home vaccine producers are given the choice to supply 25 per cent of their month-to-month manufacturing of vaccines to non-public hospitals.
In response to the revised pointers which got here into impact from June 21, vaccine doses supplied freed from value by the Centre might be allotted to states/UTs primarily based on standards reminiscent of inhabitants, illness burden and the progress of vaccination, and all above the age of 18 might be eligible for the free jabs.
Any wastage of vaccine will have an effect on the allocation negatively.
The states and UTs would mixture the demand of personal hospitals protecting in view equitable distribution between giant and small personal hospitals and regional stability.
“Based mostly on this aggregated demand, the Authorities of India will facilitate the provision of those vaccines to the personal hospitals and their cost by means of the Nationwide Well being Authority’s digital platform. This is able to allow the smaller and remoter personal hospitals to acquire a well timed provide of vaccines, and additional equitable entry and regional stability,” the ministry had mentioned.
The value of vaccine doses for personal hospitals could be declared by every vaccine producer, and any subsequent adjustments could be notified upfront, it mentioned.
Greater than 41.69 crore vaccine doses have been supplied to states and UTs thus far, by means of all sources, the well being ministry mentioned at present.
(Apart from the headline, this story has not been edited by NDTV employees and is printed from a syndicated feed.)